PBLA – panbela therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Panbela Announces Issuance of New Patent in the US and Canada; Patent is for Claims of a Fixed Dose Combination of Eflornithine and Sulindac
Panbela to Host First Quarter 2024 Earnings Conference Call on May 15, 2024
Acceptance of Eflornithine (DFMO) Abstract for Oral Presentation at Digestive Disease Week
Panbela Therapeutics Announces Interim Data Analysis for ASPIRE Trial Pushed to Q1 2025 [Yahoo! Finance]
Panbela Therapeutics Announces Interim Data Analysis for ASPIRE Trial Pushed to Q1 2025
Form DEFR14A Panbela Therapeutics,
Form PRER14A Panbela Therapeutics,
Form DEFA14A Panbela Therapeutics,
Form 8-K Panbela Therapeutics, For: Apr 23
Form 25-NSE Panbela Therapeutics, Filed by: Nasdaq Stock Market LLC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.